$61.87
4.11% yesterday
NYSE, Aug 12, 10:07 pm CET
ISIN
US3795772082
Symbol
GMED

Globus Medical, Inc. Class A Target price 2025 - Analyst rating & recommendation

Globus Medical, Inc. Class A Classifications & Recommendation:

Buy
67%
Hold
33%

Globus Medical, Inc. Class A Price Target

Target Price $81.60
Price $61.87
Potential
Number of Estimates 14
14 Analysts have issued a price target Globus Medical, Inc. Class A 2026 . The average Globus Medical, Inc. Class A target price is $81.60. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 21 analysts: 14 Analysts recommend Globus Medical, Inc. Class A to buy, 7 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Globus Medical, Inc. Class A stock has an average upside potential 2026 of . Most analysts recommend the Globus Medical, Inc. Class A stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 2.52 2.91
60.62% 15.47%
EBITDA Margin 22.24% 28.84%
7.49% 29.66%
Net Margin 4.09% 15.02%
47.82% 267.46%

17 Analysts have issued a sales forecast Globus Medical, Inc. Class A 2025 . The average Globus Medical, Inc. Class A sales estimate is

$2.9b
Unlock
. This is
15.86% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$3.0b 20.72%
Unlock
, the lowest is
$2.8b 10.20%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $2.5b 60.62%
2025
$2.9b 15.47%
Unlock
2026
$3.2b 8.32%
Unlock
2027
$3.4b 7.43%
Unlock
2028
$3.7b 8.06%
Unlock

14 Analysts have issued an Globus Medical, Inc. Class A EBITDA forecast 2025. The average Globus Medical, Inc. Class A EBITDA estimate is

$839m
Unlock
. This is
48.47% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$921m 62.98%
Unlock
, the lowest is
$755m 33.68%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $560m 72.65%
2025
$839m 49.72%
Unlock
2026
$935m 11.42%
Unlock
2027
$1.1b 13.18%
Unlock
2028
$1.2b 12.19%
Unlock

EBITDA Margin

2024 22.24% 7.49%
2025
28.84% 29.66%
Unlock
2026
29.67% 2.88%
Unlock
2027
31.26% 5.36%
Unlock
2028
32.45% 3.81%
Unlock

16 Globus Medical, Inc. Class A Analysts have issued a net profit forecast 2025. The average Globus Medical, Inc. Class A net profit estimate is

$437m
Unlock
. This is
135.43% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$478m 157.36%
Unlock
, the lowest is
$402m 116.61%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $103m 16.19%
2025
$437m 324.23%
Unlock
2026
$506m 15.75%
Unlock
2027
$575m 13.76%
Unlock
2028
$661m 14.96%
Unlock

Net Margin

2024 4.09% 47.82%
2025
15.02% 267.46%
Unlock
2026
16.05% 6.86%
Unlock
2027
16.99% 5.86%
Unlock
2028
18.08% 6.42%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 0.75 3.23
29.91% 330.67%
P/E 19.17
EV/Sales 2.71

16 Analysts have issued a Globus Medical, Inc. Class A forecast for earnings per share. The average Globus Medical, Inc. Class A EPS is

$3.23
Unlock
. This is
141.04% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$3.53 163.43%
Unlock
, the lowest is
$2.97 121.64%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.75 29.91%
2025
$3.23 330.67%
Unlock
2026
$3.74 15.79%
Unlock
2027
$4.25 13.64%
Unlock
2028
$4.89 15.06%
Unlock

P/E ratio

Current 46.17 81.08%
2025
19.17 58.48%
Unlock
2026
16.56 13.62%
Unlock
2027
14.56 12.08%
Unlock
2028
12.66 13.05%
Unlock

Based on analysts' sales estimates for 2025, the Globus Medical, Inc. Class A stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.14 28.64%
2025
2.71 13.57%
Unlock
2026
2.51 7.68%
Unlock
2027
2.33 6.91%
Unlock
2028
2.16 7.46%
Unlock

P/S ratio

Current 3.33 24.91%
2025
2.87 13.69%
Unlock
2026
2.65 7.68%
Unlock
2027
2.47 6.91%
Unlock
2028
2.28 7.46%
Unlock

Current Globus Medical, Inc. Class A Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Wells Fargo
Locked
Locked
Locked Aug 08 2025
Canaccord Genuity
Locked
Locked
Locked Jul 22 2025
Needham
Locked
Locked
Locked Jul 21 2025
Morgan Stanley
Locked
Locked
Locked Jul 15 2025
JMP Securities
Locked
Locked
Locked May 27 2025
BTIG
Locked
Locked
Locked May 27 2025
Truist Securities
Locked
Locked
Locked May 12 2025
Analyst Rating Date
Locked
Wells Fargo:
Locked
Locked
Aug 08 2025
Locked
Canaccord Genuity:
Locked
Locked
Jul 22 2025
Locked
Needham:
Locked
Locked
Jul 21 2025
Locked
Morgan Stanley:
Locked
Locked
Jul 15 2025
Locked
JMP Securities:
Locked
Locked
May 27 2025
Locked
BTIG:
Locked
Locked
May 27 2025
Locked
Truist Securities:
Locked
Locked
May 12 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today